Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 16;12(10):3169.
doi: 10.3390/nu12103169.

The Benefits of Flavonoids in Diabetic Retinopathy

Affiliations
Review

The Benefits of Flavonoids in Diabetic Retinopathy

Ana L Matos et al. Nutrients. .

Abstract

Diabetic retinopathy (DR), one of the most common complications of diabetes, is the leading cause of legal blindness among adults of working age in developed countries. After 20 years of diabetes, almost all patients suffering from type I diabetes mellitus and about 60% of type II diabetics have DR. Several studies have tried to identify drugs and therapies to treat DR though little attention has been given to flavonoids, one type of polyphenols, which can be found in high levels mainly in fruits and vegetables, but also in other foods such as grains, cocoa, green tea or even in red wine. Flavonoids have anti-inflammatory, antioxidant and antiviral effects. Since it is known that diabetes induces oxidative stress and inflammation in the retina leading to neuronal death in the early stages of the disease, the use of these compounds can prove to be beneficial in the prevention or treatment of DR. In this review, we summarize the molecular and cellular effects of flavonoids in the diabetic retina.

Keywords: diabetic retinopathy; flavonoids; inflammation; neuroprotection; oxidative stress; retina.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures of flavonoid subclasses.

Similar articles

Cited by

References

    1. Resnikoff S., Pascolini D., Etya’ale D., Kocur I., Pararajasegaram R., Pokharel G.P., Mariotti S.P. Global data on visual impairment in the year 2002. Bull. World Health Organ. 2004;82:844–851. - PMC - PubMed
    1. Thomas R.L., Halim S., Gurudas S., Sivaprasad S., Owens D.R. IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res. Clin. Pract. 2019;157:107840. doi: 10.1016/j.diabres.2019.107840. - DOI - PubMed
    1. Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
    1. Fong D.S., Aiello L., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris F.L., Klein R. Retinopathy in diabetes. Diabetes Care. 2004;27:s84–s87. doi: 10.2337/diacare.27.2007.S84. - DOI - PubMed
    1. Ligda G., Ploubidis D., Foteli S., Kontou P.I., Nikolaou C., Tentolouris N. Quality of life in subjects with type 2 diabetes mellitus with diabetic retinopathy: A case–control study. Diabetes Metab. Syndr. Clin. Res. Rev. 2019;13:947–952. doi: 10.1016/j.dsx.2018.12.012. - DOI - PubMed

MeSH terms